Heslegrave A, Heywood W, Paterson R, Magdalinou N, Svensson J, Johansson P, Öhrfelt A, Blennow K, Hardy J, Schott J, Mills K, Zetterberg H. Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease. Mol Neurodegener. 2016 Jan 12;11:3. PubMed.
AlzBiomarker Database
Meta-Analysis
Curated Study Data
| Biomarker (Source) |
Cohort (N) |
Measurement Mean ± SD |
Method; Assay Name; Manufacturer |
Diagnostic Criteria |
|---|---|---|---|---|
| sTREM2 (CSF) |
AD (24) |
248.8 ± 102.6 ng/L § |
Mass Spectrometry; In-house; In-house |
|
| sTREM2 (CSF) |
AD (37) |
241 ± 93.7 ng/L § |
Mass Spectrometry; In-house; In-house |
|
| sTREM2 (CSF) |
CTRL- CNC (16) |
192.3 ± 59.3 ng/L § |
Mass Spectrometry; In-house; In-house |
|
| sTREM2 (CSF) |
CTRL- Other Controls (22) |
192.9 ± 63.7 ng/L § |
Mass Spectrometry; In-house; In-house |
§ Data supplied to Alzforum by author
Recommends
Please login to recommend the paper.
Comments
No Available Comments
Make a Comment
To make a comment you must login or register.